Ascletis Pharma is a biopharmaceutical company based in China that develops and commercialises medicines for viral hepatitis and liver disease. Its work centres on treatments for hepatitis B and hepatitis C, and it has expanded into other areas such as liver fibrosis and cancer therapies. The company serves patients and healthcare providers in China, combining its own research with clinical development and marketing of its products.
On this site Ascletis Pharma Inc appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 1672, with prices in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2163 of 2613 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
9/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-54.4%
From 52-week high-70.6%
MomentumWeak
25/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-36.3%
6-month return-69.0%
12-month, skipping last month0.7%
Stability (higher is calmer)Weak
22/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)76.2%
Worst drawdown, 1 year (smaller is calmer)-71.2%
LiquidityStrong
80/100
Trades actively.
See the numbers →
Avg daily value traded20.92M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 5.400 – 19.860Daily closes, split-adjusted
Signals
50-day average8.746
200-day average12.365
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.629
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
6.09
Bearish
EMA 10
6.21
Bearish
SMA 20
7.24
Bearish
EMA 20
6.98
Bearish
SMA 50
8.75
Bearish
EMA 50
8.30
Bearish
SMA 100
9.37
Bearish
EMA 100
9.65
Bearish
SMA 200
12.37
Bearish
EMA 200
10.75
Bearish
Oscillators (daily)
RSI (14)
28.62
Bullish
MACD (12, 26)
-0.95
Bearish
Momentum (12)
-38.18
Bearish
Stochastic %K (14)
6.18
Bullish
Williams %R (14)
-93.82
Bullish
CCI (20)
-100.9
Bullish
Pivot points (classic, last session)
S3
5.19
S2
5.31
S1
5.47
Pivot
5.60
R1
5.76
R2
5.88
R3
6.04
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
